Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_assertion type Assertion NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_head.
- NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_assertion description "[This includes the discovery that the pathological changes in atypical FTLD with ubiquitinated inclusions, neuronal intermediate filament inclusion disease, and basophilic inclusion body disease are immunoreactive for the fused in sarcoma (FUS) protein, resulting in the creation of a new molecular subgroup (FTLD-FUS), and studies clarifying the functional consequences of pathogenic CHMP2B mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_provenance.
- NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_assertion evidence source_evidence_literature NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_provenance.
- NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_assertion SIO_000772 21603977 NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_provenance.
- NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_assertion wasDerivedFrom befree-2016 NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_provenance.
- NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_assertion wasGeneratedBy ECO_0000203 NP896088.RALWf-BdYm39dBwE5u6GmOTicQKh3nzjrPItPCGx8rgns130_provenance.